Induction therapy in newly diagnosed multiple myeloma: Current research scenario and questions for the future
The outcomes of patients with newly diagnosed multiple myeloma (NDMM) have substantially improved over the last decade. Besides improved staging, diagnostic and prognostic tools leading to better risk-stratified approaches, a major contributing factor has been better induction regimens. The major em...
Main Authors: | Bhausaheb Bagal, Avinash Bonda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Subjects: | |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=76;epage=82;aulast=Bagal |
Similar Items
-
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
by: Friederike Bachmann, et al.
Published: (2021-03-01) -
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
by: Massimo Offidani, et al.
Published: (2021-02-01) -
Induction regimens for transplant-eligible patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
by: Zeng ZH, et al.
Published: (2017-07-01) -
The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
by: E. Zamagni, et al.
Published: (2020-12-01) -
The Impact of Induction Regimes on Immune Responses in Patients with Multiple Myeloma
by: Michael A. Firer, et al.
Published: (2021-08-01)